Art

J-GLOBAL ID：201302228754700306   Reference number：13A1492910

認知症者に向精神薬をどのように使うのか アルツハイマー病治療薬の最近の話題

Author (1)： HANYU HARUO (東京医大 高齢診療科)
Material： 老年精神医学雑誌  (Japanese Journal of Geriatric Psychiatry)
Volume： 24  Issue： 8  Page： 791-798  Publication year： Aug. 20, 2013 
JST Material Number： L1147A  ISSN： 0915-6305  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： Alzheimer Disease ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1492910&from=J-GLOBAL&jstjournalNo=L1147A") }}

JST classification (2)： Clinical application of other drugs acting on central nervous system  (GW03130F) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Substance index (2)： Donepezil ,  Memantine

Reference (16)：

• 1) Atri A, Molinuevo JL, Lemming O, Wirth Y, et al.: Memantine in patients with Alzheimer's disease receiving donepezil ; New analyses of efficacy and safety for combination therapy. Alzheimcrs Res Ther,5 (1) : 6 (2013).
• 2) Baker NL, Cook MN, Arrighi HM, Bullock R : Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007. Age Ageing, 40 : 49-54 (2011).
• 3) Engedal K, Davis B, Richarz U, Han J, et al.: Two galantamine titration regimens in patients switched from donepezil. Acta Neurol Scand, 126 : 37-44 (2012).
• 4) Farlow MR, Cummings JL : Effective pharmacologic management of Alzheimer's disease. Am J Med, 120 : 388-397 (2007).
• 5) Howard R, McShane R, Lindesay J, Ritchie C, et al.: Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Eng J Med, 366 : 893-903 (2012).

Terms in the title (4)： 認知症 ,  向精神薬 ,  アルツハイマー病治療薬 ,  話題